Abstract:
The present invention relates to compounds useful as inhibitors of protein kinase. The invention also provides pharmaceutically acceptable compositions comprising said compounds and methods of using the compositions in the treatment of various disease, conditions, or disorders. The invention also provides processes for preparing compounds of the inventions.
Abstract:
The present invention relates to compounds useful as inhibitors of protein kinase. The invention also relates to pharmaceutically acceptable compositions comprising said compounds and methods of using the compounds and the compositions in the treatment of various disease, conditions, or disorders. The invention also relates to processes for preparing compounds of the inventions.
Abstract:
The present invention provides compounds of Formula (I'), or pharmaceutically acceptable salts thereof, pharmaceutical compositions thereof, and methods of use thereof for treating cellular proliferative disorders (e.g. cancer).
Abstract:
Un proceso para preparación de un compuesto de fórmula 5: **Fórmula** que comprende el paso de someter selectivamente a des-cloración un compuesto de fórmula 1: 5 **Fórmula** en condiciones de des-cloración adecuada para formar un compuesto de fórmula 2: **Fórmula**
Abstract:
Disclosed are compounds of formula (I), wherein the substituents are as defined in the specification. The compounds are protein kinase inhibitors particularly useful as GSK-3 inhibitors. The compounds are used in the manufacture of a medicament for treating or lessening the severity of a disease or condition selected from diabetes, Alzheimer's disease, Huntington's disease, Parkinson's disease, AIDS-associated dementia, bipolar disorder, amyotrophic lateral sclerosis (ALS, Lou Gehrig's disease), multiple sclerosis (MS), schizophrenia, leukocytopenia, cardiomyocyte hypertrophy, stroke, and rheumatoid arthritis.
Abstract:
La presente invención se relaciona con compuestos de la fórmula (I) y (IA) útiles como inhibidores de la proteína cinasa (1ª). La invención también proporciona composiciones farmacéuticamente aceptables que comprenden tales compuestos y métodos para usar las composiciones en el tratamiento de diferentes enfermedades, afecciones o trastornos. La invención también proporciona procesos para preparar compuestos de las invenciones. (a): en particular la proteína cinasa Ctheta, en donde A y A' son independientemente -N- o C(R+)-. El anillo B es de cinco o seis miembros saturado carbocíclico o heterocíclico, R1, R2, r3, R4, R5, R6, R7, x y y son como se describen en la presente. (ver fórmula anexa).
Abstract:
The present invention relates to compounds of formula (I) and (IA) useful as inhibitors of protein kinase (1a). The invention also provides pharmaceutically acceptable compositions comprising said compounds and methods of using the compositions in the treatment of various disease, conditions, or disorders. The invention also provides processes for preparing compounds of the inventions. (a) : in particular protein kinase C theta, wherein A and A' are independently -N- or -C(R+) -. Ring B is five- or six-membered saturated carbocyclic or heterocyclic R1, R2, R3, R4, R5, R6, R7, x and y are as described herein.